Glaxo Says Its COVID-19 Antibody Treatment Effective Against Omicron

Contact Your Elected Officials
The Epoch Times Header

British drugmaker GlaxoSmithKline said early-stage lab data shows its COVID-19 monoclonal antibody treatment, jointly developed with U.S. partner Vir Biotechnology, is effective against all mutations of the new Omicron strain.

Glaxo said in a Dec. 7 statement that new preclinical findings generated from in vitro testing of the drug, called sotrovimab, show that the treatment is effective against all 37 identified mutations to date in Omicron’s spike protein.

“These pre-clinical data demonstrate the potential for our monoclonal antibody to be effective against the latest variant, Omicron, plus all other variants of concern defined to date” by the World Health Organization (WHO), said Dr. Hal Barron, Chief Scientific Officer and President of Research and Development, at GSK.

The data, which has not yet been peer reviewed, builds on earlier preclinical findings released last week, which showed sotrovimab was effective against key Omicron mutations.

“Sotrovimab is the first monoclonal antibody to report preclinical data demonstrating activity against all tested SARS-CoV-2 variants of concern and interest to date, including Omicron, as well as the still prevalent and highly contagious Delta variant,” George Scangos, CEO of Vir Biotechnology, said in a statement.

SARS-CoV-2 is the scientific name for the CCP (Chinese Communist Party) virus, the pathogen that causes the disease COVID-19.

While much remains unknown about Omicron, which has been detected in dozens of countries including the United States, it appears to spread more quickly than other variants, though early signs from a study in South Africa suggest it may cause milder illness.

Sotrovimab has been approved for emergency use by the U.S. Food and Drug Administration (FDA) and recently gained approval for use in the United Kingdom.

The FDA authorized the antibody treatment for use in people who have mild to moderate COVID-19 and who are at high risk for progression to severe disease.

By Tom Ozimek

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Why Democracy, not Caesar, is the answer to our problems

Caesar-style leadership wins quick public support but inevitably sparks passionate resistance, conflict, bloodshed, and lasting social destabilization.

WATCH: Barack Obama Foments Color Revolutions in Eastern Europe

Obama astroturfed “pro-democracy” movements in Poland and Hungary to pressure their govts into accepting mass migration and social engineering.

J.B. Pritzker Puts the ILLeagals in ILLinois

Illinois Gov. J.B. Pritzker, once a California native, has revived the old “ILL” abbreviation—this time in his promotion of ILLegal aliens.

James Franklin’s contract fallout

Penn State’s decision to fire head coach James Franklin after a disappointing 22–21 home loss to Northwestern will cost an estimated $56 million buyout. 

Trump’s Middle East Trip Led to Historic Breakthroughs

Trump’s bold, unconventional strategy helped end the Israel-Hamas war and set the stage for a more stable, prosperous Middle East.

Jack Smith Referred to DOJ for Misconduct Investigation and Possible Disbarment

Former special counsel Jack Smith was criminally referred to the DOJ by Republican lawmakers for alleged misconduct and possible disbarment.

AI Is a ‘Real and Mysterious Creature,’ Not a Predictable Machine, Anthropic Co-Founder Warns

Handling AI is like dealing with “a real and mysterious creature, not a predictable machine,” said Jack Clark, co-founder of Anthropic, at a Berkeley conference.

Trump Refiles $15 Billion Defamation Lawsuit Against New York Times After Court Dismissal

Trump refiled his $15 billion defamation lawsuit against The New York Times, Penguin Random House, and 3 reporters after judge dismissed the case.

US Chamber of Commerce Sues Trump Over $100,000 H-1B Visa Fee

The U.S. Chamber of Commerce filed a lawsuit challenging President Donald Trump’s $100,000 fee on new H-1B visas for foreign workers.

Trump Signs Executive Order Putting New Restrictions on Federal Hiring

Trump signed an executive order directing federal agencies to restrict hiring, with exceptions for immigration, security, and political appointees.

Trump Says He Has Authorized Covert CIA Operations in Venezuela

President Trump authorized covert CIA operations in Venezuela, expanding U.S. assets there to increase pressure on President Nicolás Maduro’s regime.

Trump Posthumously Awards Charlie Kirk the Presidential Medal of Freedom

President Trump posthumously awarded Charlie Kirk the Presidential Medal of Freedom in the White House Rose Garden on Oct 14, Charlie's birthday.

Social Security Says 2026 Payments Will Be Adjusted Despite Shutdown

Social Security will announce next year’s COLA; the ongoing government shutdown won’t affect 2026 payments, the SSA confirmed Tuesday.
spot_img

Related Articles

Popular Categories

MAGA Business Central